Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

28.88 +0.05 (+0.19%)
Streaming Delayed Price Updated: 9:30 AM EDT, Jun 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,926
Open 28.75
Bid (Size) 28.65 (100)
Ask (Size) 29.10 (200)
Prev. Close 28.82
Today's Range 28.75 - 28.88
52wk Range 10.96 - 29.07
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CareDx's CEO Sells 17K Shares ↗
CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions. 
Via The Motley Fool
Topics Regulatory Compliance
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests ↗
Via Chartmill

Performance

YTD
+50.9%
+50.9%
1 Month
+26.5%
+26.5%
3 Month
+75.7%
+75.7%
6 Month
+50.4%
+50.4%
1 Year
+47.8%
+47.8%

More News

Read More
News headline image
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
From CareDx, Inc.
Via Business Wire
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup ↗
Via Chartmill
CareDx (NASDAQ:CDNA) Beats Q1 Estimates and Raises Full-Year Guidance, But Stock Slips ↗
Via Chartmill
CareDx Inc (NASDAQ:CDNA) Reports Strong Revenue Beat but Profitability Concerns Weigh on Shares ↗
Via Chartmill
News headline image
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans ↗
Via MarketBeat
Topics Intellectual Property
News headline image
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies ↗
Via MarketBeat
News headline image
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Dismissal of 2021 Qui Tam Suit
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
News headline image
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces First Quarter 2026 Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q2 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
From CareDx, Inc.
Via Business Wire
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is CareDx, Inc. - Common Stock publicly traded?
Yes, CareDx, Inc. - Common Stock is publicly traded.
What exchange does CareDx, Inc. - Common Stock trade on?
CareDx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CareDx, Inc. - Common Stock?
The ticker symbol for CareDx, Inc. - Common Stock is CDNA on the Nasdaq Stock Market
What is the current price of CareDx, Inc. - Common Stock?
The current price of CareDx, Inc. - Common Stock is 28.88
When was CareDx, Inc. - Common Stock last traded?
The last trade of CareDx, Inc. - Common Stock was at 06/29/26 09:30 AM ET
What is the market capitalization of CareDx, Inc. - Common Stock?
The market capitalization of CareDx, Inc. - Common Stock is 1.52B
How many shares of CareDx, Inc. - Common Stock are outstanding?
CareDx, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.